Facebook Linkedin RSS Twitter Youtube
Home 2024

Moderna

Biomanufacturing for the Next Pandemic
Bioprocessing

Biomanufacturing for the Next Pandemic

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors
Drug Discovery

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors

Mpox Protection: Moderna’s New mRNA Vaccine May Beat Today’s MVA Shot
Infectious Diseases

Mpox Protection: Moderna’s New mRNA Vaccine May Beat Today’s MVA Shot

Prioritize Drug Candidates Efficiently and Cost-Effectively with Organ-Chips
Drug Discovery

Prioritize Drug Candidates Efficiently and Cost-Effectively with Organ-Chips

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Entos Expands In-House Manufacturing with GMP Facility
Bioprocessing

Entos Expands In-House Manufacturing with GMP Facility

Moderna Reports Phase I/II Data for Propionic Acidemia mRNA Therapy
Drug Discovery

Moderna Reports Phase I/II Data for Propionic Acidemia mRNA Therapy

Digital In Vitro Transcription Models Could Aid mRNA Manufacturing
Bioprocessing

Digital In Vitro Transcription Models Could Aid mRNA Manufacturing

StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates
Drug Discovery

StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates

Vaccines in Development
Infectious Diseases

Vaccines in Development

123...10Page 1 of 10
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.